Skip to main content
. 2018 Mar;10(3):1972–1983. doi: 10.21037/jtd.2018.03.49

Table 2. Published studies of CP-EBUS and RP-EBUS facilitated FM placement.

Author and year Patients (number) Location Fiducial MIG (Y/N) MC rates (%) Equipment
Anantham 2007 8 P Gold seeds Y 0 SuperD/Bronchus/CyberKnife
Schroeder 2010 52 P Gold markers; platinum coils N 5.8% SuperD/CyberKnife
Harley 2010 43 C/P Gold markers Y 2.3% SuperD/CP-EBUS/CyberKnife
Roman 2012 6 C/P Gold visicoil N N SuperD/CP-EBUS
Hagmeyer 2014 6 P Gold markers Y 0 SuperD/CyberKnife
Nabavizadeh 2014 31 P Platinum coils N (<2%) 3.2% SuperD/RP-EBUS/Novalis SBRT
Steinfort 2015 15 P Gold visicoil Y 0 SuperD/RPUS
Belanger 2016 5 C Gold (NOS) N 0 CP-EBUS/CyberKnife
Casutt 2017 1 C Gold visicoil N 0 CP-EBUS/CyberKnife
Chambers 2017 1 C Microembolization coil (cook) N 0 CP-EBUS/IMRT
Khandhar 2017 210 P Unknown (pooled data) Y 5.7% ENB (NOS)

CP-EBUS, convex probe endobronchial ultrasound; RP-EBUS, radial probe endobronchial ultrasound; FM, fiducial marker; P, peripheral; C, central; MC, major complication; MIG, migration; NOS, not otherwise specified; SuperD, SuperDimension; SBRT, stereotactic body radiation therapy; IMRT, intensity modulated radiation therapy; ENB, electromagnetic navigation bronchoscopy; Y, yes; N, no.